Haemonetics
295 hedge funds and large institutions have $4.36B invested in Haemonetics in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 91 increasing their positions, 118 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $4.55B → $4.36B (-$189M)
23% less repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 118
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
295
Holding in Top 10
–
Calls
$16M
Puts
$4.78M
Top Buyers
| 1 | +$32.1M | |
| 2 | +$22.1M | |
| 3 | +$21M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$13M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$9.01M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$12.9M | |
| 3 | -$12.8M | |
| 4 |
CCM
Cinctive Capital Management
New York
|
-$12.5M |
| 5 |
LCP
LGT Capital Partners
Pfaeffikon,
Switzerland
|
-$10M |